EBR Systems, Inc.
EBRCZ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$101.7M
Close$
$-0.10
191.4% downside
Current Fair Value
191.4% downsideOvervalued by 191.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $101.70 Million |
|---|---|
| Enterprise Value | $119.46 Million |
| Earnings per Share | $-0.12 |
| Beta | 0.52 |
| Outstanding Shares | 492,361,290 |
Return
| Return on Equity | -87.96% |
|---|---|
| Return on Assets | -43.67% |
| Return on Invested Capital | -64.99% |
Valuation & Multiples
| P/E Ratio | -0.97 |
|---|---|
| PEG | -2.31 |
| Price to Sales | 0.11 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.23 |
| Enterprise Value to EBIT | -2.12 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.65 |
| Debt to Equity | 1.12 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 12, 2026
EPS Estimate
$-0.03
Consensus analyst estimateRevenue Estimate
$3.50 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.03
Consensus analyst estimateRevenue Estimate
$3.50 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About EBR Systems, Inc.
135 employees
CEO: John Graham McCutcheon
EBR Systems, Inc. is a company focused on creating implantable medical devices that employ wireless technology for tissue stimulation. Their flagship product is the WiSE cardiac resynchronization therapy system, which utilizes a unique w...